Pay in 4 interest-free payments of $6.09 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
1991 (landmark Italian trial): A double-blind, placebo-controlled trial involving 130 patients with Alzheimer's disease demonstrated that one year of ALCAR treatment resulted in a slower rate of deterioration compared to placebo across 13 of 14 outcome measures, including significant improvements in the Blessed Dementia Scale, logical intelligence, verbal critical abilities, long-term verbal memory, and selective attention [5][17]
It was FDA-approved in 2010 as a weight loss medication for Netherlands HIV patients suffering from lipodystrophy, a condition that leads to an accumulation of fat (adipose tissue) in the abdominal area
Increasing your dose before your body has acclimated increases the risk of side effects including nausea, vomiting, and GI discomfort
A 0.20 mL draw delivers 0.5 mg cag + 0.5 mg tirz
US$ 23.90
US$ 24.12
US$ 22.10
US$ 24.94
